Altogether, our in vivo results indicate that AT1-R blockade favors increased cholinergic activity and decreased inflammatory milieu in AD-affected brain tissue, which in turn could explain the improved cognitive performance of losartan treated mice. Here, AGTR1 is linked to Alzheimer disease.